CA
Calton & Associates Portfolio holdings
AUM
$578M
1-Year Return
14.11%
This Quarter Return
+12.46%
1 Year Return
+14.11%
3 Year Return
+51.24%
5 Year Return
+87.72%
10 Year Return
–
AUM
$560M
AUM Growth
+$73.4M
(+15%)
Cap. Flow
+$19.5M
Cap. Flow
% of AUM
3.49%
Top 10 Holdings %
Top 10 Hldgs %
35.89%
Holding
404
New
56
Increased
149
Reduced
167
Closed
22
Top Buys
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$11.7M |
| 2 |
iShares Core Total USD Bond Market ETF
IUSB
|
+$6.9M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$6.17M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$5.19M |
| 5 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$4.7M |
Top Sells
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$10.4M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$6.55M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$4.15M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$4.14M |
| 5 |
IMMU
Immunomedics Inc
IMMU
|
+$3.79M |
Sector Composition
| 1 | Technology | 6.95% |
| 2 | Healthcare | 3.72% |
| 3 | Financials | 2.67% |
| 4 | Consumer Discretionary | 2.34% |
| 5 | Communication Services | 1.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Allstate
ALL
$52.9B
| $286K | 0.05% |
2,599
+132
| +5% | +$14.5K |
|
277
Five Below
FIVE
$7.82B
| $286K | 0.05% |
1,635
-64
| -4% | -$11.2K |
|
278
Oneok
OKE
$45.5B
| $285K | 0.05% |
7,413
-899
| -11% | -$34.6K |
|
279
ARK Innovation ETF
ARKK
$7.17B
| $284K | 0.05% |
+2,281
| New | +$284K |
|
280
Vanguard Small-Cap Growth ETF
VBK
$20.3B
| $284K | 0.05% |
1,059
-99
| -9% | -$26.6K |
|
281
Eaton
ETN
$135B
| $283K | 0.05% |
2,358
+177
| +8% | +$21.2K |
|
282
Applied Materials
AMAT
$130B
| $280K | 0.05% |
+3,249
| New | +$280K |
|
283
Fidelity Corporate Bond ETF
FCOR
$289M
| $276K | 0.05% |
4,814
+943
| +24% | +$54.1K |
|
284
Nike
NKE
$108B
| $275K | 0.05% |
1,944
-143
| -7% | -$20.2K |
|
285
Travere Therapeutics
TVTX
$1.89B
| $275K | 0.05% |
10,085
-368
| -4% | -$10K |
|
|
GBT
286
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $272K | 0.05% |
6,288
+593
| +10% | +$25.7K |
|
287
VanEck High Yield Muni ETF
HYD
$3.34B
| $270K | 0.05% |
4,394
+110
| +3% | +$6.76K |
|
288
iShares 20+ Year Treasury Bond ETF
TLT
$49.2B
| $266K | 0.05% |
1,688
-240
| -12% | -$37.8K |
|
289
UGI
UGI
$7.38B
| $266K | 0.05% |
7,616
-212
| -3% | -$7.4K |
|
290
Schwab US Dividend Equity ETF
SCHD
$71.5B
| $265K | 0.05% |
+12,396
| New | +$265K |
|
|
XLRN
291
DELISTED
Acceleron Pharma Inc.
XLRN
| $262K | 0.05% |
2,050
-81
| -4% | -$10.4K |
|
292
Vanguard Intermediate-Term Treasury ETF
VGIT
$32.4B
| $261K | 0.05% |
3,764
| – | – |
|
293
AES
AES
$9.11B
| $260K | 0.05% |
11,081
-346
| -3% | -$8.12K |
|
294
Citigroup
C
$180B
| $259K | 0.05% |
+4,202
| New | +$259K |
|
295
NeoGenomics
NEO
$1.02B
| $259K | 0.05% |
+4,805
| New | +$259K |
|
296
Zoom
ZM
$25.5B
| $259K | 0.05% |
767
+210
| +38% | +$70.9K |
|
297
Sarepta Therapeutics
SRPT
$1.85B
| $258K | 0.05% |
+1,516
| New | +$258K |
|
298
Align Technology
ALGN
$10.1B
| $257K | 0.05% |
+480
| New | +$257K |
|
299
First Trust Europe AlphaDEX Fund
FEP
$337M
| $255K | 0.05% |
+6,686
| New | +$255K |
|
300
WisdomTree International SmallCap Dividend Fund
DLS
$1.05B
| $253K | 0.05% |
3,719
-305
| -8% | -$20.7K |
|